Henry Ford Health System has selected its own Steven N. Kalkanis, M.D., to serve as the Chief Executive Officer of the Henry Ford Medical Group (HFMG), effective Jan. 1, 2020.
Dr. Kalkanis will provide strategic leadership and direction for the 1,900-member group of physicians and researchers, who are responsible for all aspects of clinical performance across 40 specialties.
Additionally, Kalkanis will also serve as Henry Ford’s Senior Vice President and Chief Academic Officer, working to advance the health system’s academic mission, including the development and advancement of all research and medical education programs.
Kalkanis joined Henry Ford in 2004 and is currently the Chair of the health system’s Department of Neurosurgery, ranked among the nation’s best by U.S. News and World Report.
He is also the Medical Director of the Henry Ford Cancer Institute, leading the expansion of cancer care services across the system, including the spearheading of a comprehensive precision medicine and molecular tumor board program for all cancer types, and the development of the health system’s new destination cancer facility, expected to open in 2020.
“I am honored to follow in the footsteps of such a storied and respected leader of the Henry Ford Medical Group,” said Dr. Kalkanis. “To have the opportunity to be part of a compassionate and diverse culture that is relentless in its pursuit of clinical innovation, pioneering research and next generation medical education has been a privilege.”
“In this new capacity, I am more committed than ever to stewarding transformational healthcare through a combination of precision medicine and digital advancements, distinctly personalized care, value-based solutions and a dedication to addressing the real challenges in our communities,” he added.